Recombinant Immunotherapeutics Market Report

China Recombinant Immunotherapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Aug 29, 2023
  • PAGES：169
  • REPORT CODE：GMM1764929
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Recombinant Immunotherapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Capricor

    • Janssen

    • UCB

    • GlaxoSmithKline

    • United Therapeutics

    • Octapharma

    • AstraZeneca

    • Grifols

    • Takeda

    • NeuroDerm

    • Ferring

    • SteadyMed

    • Baxter

    • Britannia

    • Amgen

    • Rhythm Metabolic

    • Roche

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Medical care

    • Hospital

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Recombinant Immunotherapeutics Market Overview 2018-2029

    • 1.1 China Recombinant Immunotherapeutics Industry Development Overview

    • 1.2 China Recombinant Immunotherapeutics Industry Development History

    • 1.3 China Recombinant Immunotherapeutics Industry Market Size (2018-2029)

    • 1.4 China Recombinant Immunotherapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Recombinant Immunotherapeutics Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Recombinant Immunotherapeutics Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Recombinant Immunotherapeutics Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Recombinant Immunotherapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Recombinant Immunotherapeutics Sales Volume, Sales Value and Growth Rate of Medical care (2018-2029)

      • 1.5.2 China Recombinant Immunotherapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • 1.6 China Recombinant Immunotherapeutics Market Analysis by Region

      • 1.6.1 North China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Recombinant Immunotherapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Recombinant Immunotherapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Recombinant Immunotherapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Recombinant Immunotherapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Recombinant Immunotherapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Recombinant Immunotherapeutics Industry Development

    Chapter 3 Recombinant ImmunotherapeuticsIndustry Chain Analysis

    • 3.1 Recombinant Immunotherapeutics Industry Chain

    • 3.2 Recombinant Immunotherapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Recombinant Immunotherapeutics Market

    • 3.3 Recombinant Immunotherapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Recombinant Immunotherapeutics Market

    Chapter 4 China Recombinant Immunotherapeutics Market, by Type

    • 4.1 China Recombinant Immunotherapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Recombinant Immunotherapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Recombinant Immunotherapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Recombinant Immunotherapeutics Production Volume and Growth Rate of Type 1

      • 4.5.2 China Recombinant Immunotherapeutics Production Volume and Growth Rate of Type 2

      • 4.5.3 China Recombinant Immunotherapeutics Production Volume and Growth Rate of Type 3

    Chapter 5 China Recombinant Immunotherapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Recombinant Immunotherapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Recombinant Immunotherapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Recombinant Immunotherapeutics Market Size and Growth Rate of Medical care

      • 5.5.2 China Recombinant Immunotherapeutics Market Size and Growth Rate of Hospital

    Chapter 6 China Recombinant Immunotherapeutics Market, by Region

    • 6.1 China Recombinant Immunotherapeutics Production Volume and Production Value, by Region

    • 6.2 China Recombinant Immunotherapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Recombinant Immunotherapeutics Market Analysis

    • 7.1 North China Recombinant Immunotherapeutics Market, by Type

    • 7.2 North China Recombinant Immunotherapeutics Market, by Application

    Chapter 8 Central China Recombinant Immunotherapeutics Market Analysis

    • 8.1 Central China Recombinant Immunotherapeutics Market, by Type

    • 8.2 Central China Recombinant Immunotherapeutics Market, by Application

    Chapter 9 South China Recombinant Immunotherapeutics Market Analysis

    • 9.1 South China Recombinant Immunotherapeutics Market, by Type

    • 9.2 South China Recombinant Immunotherapeutics Market, by Application

    Chapter 10 East China Recombinant Immunotherapeutics Market Analysis

    • 10.1 East China Recombinant Immunotherapeutics Market, by Type

    • 10.2 East China Recombinant Immunotherapeutics Market, by Application

    Chapter 11 Northeast China Recombinant Immunotherapeutics Market Analysis

    • 11.1 Northeast China Recombinant Immunotherapeutics Market, by Type

    • 11.2 Northeast China Recombinant Immunotherapeutics Market, by Application

    Chapter 12 Southwest China Recombinant Immunotherapeutics Market Analysis

    • 12.1 Southwest China Recombinant Immunotherapeutics Market, by Type

    • 12.2 Southwest China Recombinant Immunotherapeutics Market, by Application

    Chapter 13 Northwest China Recombinant Immunotherapeutics Market Analysis

    • 13.1 Northwest China Recombinant Immunotherapeutics Market, by Type

    • 13.2 Northwest China Recombinant Immunotherapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Capricor

        • 14.1.1 Capricor Company Profile

        • 14.1.2 Capricor Recombinant Immunotherapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Janssen

        • 14.2.1 Janssen Company Profile

        • 14.2.2 Janssen Recombinant Immunotherapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 UCB

        • 14.3.1 UCB Company Profile

        • 14.3.2 UCB Recombinant Immunotherapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 GlaxoSmithKline

        • 14.4.1 GlaxoSmithKline Company Profile

        • 14.4.2 GlaxoSmithKline Recombinant Immunotherapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 United Therapeutics

        • 14.5.1 United Therapeutics Company Profile

        • 14.5.2 United Therapeutics Recombinant Immunotherapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Octapharma

        • 14.6.1 Octapharma Company Profile

        • 14.6.2 Octapharma Recombinant Immunotherapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 AstraZeneca

        • 14.7.1 AstraZeneca Company Profile

        • 14.7.2 AstraZeneca Recombinant Immunotherapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Grifols

        • 14.8.1 Grifols Company Profile

        • 14.8.2 Grifols Recombinant Immunotherapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Takeda

        • 14.9.1 Takeda Company Profile

        • 14.9.2 Takeda Recombinant Immunotherapeutics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 NeuroDerm

        • 14.10.1 NeuroDerm Company Profile

        • 14.10.2 NeuroDerm Recombinant Immunotherapeutics Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Ferring

        • 14.11.1 Ferring Company Profile

        • 14.11.2 Ferring Recombinant Immunotherapeutics Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 SteadyMed

        • 14.12.1 SteadyMed Company Profile

        • 14.12.2 SteadyMed Recombinant Immunotherapeutics Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Baxter

        • 14.13.1 Baxter Company Profile

        • 14.13.2 Baxter Recombinant Immunotherapeutics Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Britannia

        • 14.14.1 Britannia Company Profile

        • 14.14.2 Britannia Recombinant Immunotherapeutics Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Amgen

        • 14.15.1 Amgen Company Profile

        • 14.15.2 Amgen Recombinant Immunotherapeutics Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Rhythm Metabolic

        • 14.16.1 Rhythm Metabolic Company Profile

        • 14.16.2 Rhythm Metabolic Recombinant Immunotherapeutics Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Roche

        • 14.17.1 Roche Company Profile

        • 14.17.2 Roche Recombinant Immunotherapeutics Market Performance

        • 14.17.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Recombinant Immunotherapeutics Industry Research Conclusions

    • 15.2 Recombinant Immunotherapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Recombinant Immunotherapeutics Industry Market Size (2018-2029)

    • Figure China Recombinant Immunotherapeutics Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Recombinant Immunotherapeutics Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Recombinant Immunotherapeutics Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Recombinant Immunotherapeutics Sales Volume, Sales Value and Growth Rate of Medical care (2018-2029)

    • Figure China Recombinant Immunotherapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure North China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Recombinant Immunotherapeutics Market Size and Growth Rate from 2018-2029

    • Figure Recombinant Immunotherapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Recombinant Immunotherapeutics Market Share by Type in 2018

    • Figure China Recombinant Immunotherapeutics Market Share by Type in 2023

    • Figure China Recombinant Immunotherapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Recombinant Immunotherapeutics Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Recombinant Immunotherapeutics Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Recombinant Immunotherapeutics Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Recombinant Immunotherapeutics Market Share by Application in 2018

    • Figure China Recombinant Immunotherapeutics Market Share by Application in 2023

    • Figure China Recombinant Immunotherapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Recombinant Immunotherapeutics Market Size and Growth Rate of Medical care (2018-2023)

    • Figure China Recombinant Immunotherapeutics Market Size and Growth Rate of Hospital (2018-2023)

    • Table China Recombinant Immunotherapeutics Production Volume by Region (2018-2023)

    • Table China Recombinant Immunotherapeutics Production Volume Share by Region (2018-2023)

    • Figure China Recombinant Immunotherapeutics Production Volume Share by Region (2018-2023)

    • Table China Recombinant Immunotherapeutics Production Value by Region (2018-2023)

    • Table China Recombinant Immunotherapeutics Production Value Share by Region (2018-2023)

    • Figure China Recombinant Immunotherapeutics Production Value Share by Region (2018-2023)

    • Table China Recombinant Immunotherapeutics Sales Volume by Region (2018-2023)

    • Table China Recombinant Immunotherapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Recombinant Immunotherapeutics Sales Volume Share by Region (2018-2023)

    • Table China Recombinant Immunotherapeutics Sales Value by Region (2018-2023)

    • Table China Recombinant Immunotherapeutics Sales Value Share by Region (2018-2023)

    • Figure China Recombinant Immunotherapeutics Sales Value Share by Region (2018-2023)

    • Table North China Recombinant Immunotherapeutics Production Volume by Type (2018-2023)

    • Table North China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Table North China Recombinant Immunotherapeutics Sales Volume by Application (2018-2023)

    • Table North China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Recombinant Immunotherapeutics Production Volume by Type (2018-2023)

    • Table Central China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Recombinant Immunotherapeutics Sales Volume by Application (2018-2023)

    • Table Central China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Recombinant Immunotherapeutics Production Volume by Type (2018-2023)

    • Table South China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Table South China Recombinant Immunotherapeutics Sales Volume by Application (2018-2023)

    • Table South China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Recombinant Immunotherapeutics Production Volume by Type (2018-2023)

    • Table East China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Table East China Recombinant Immunotherapeutics Sales Volume by Application (2018-2023)

    • Table East China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Recombinant Immunotherapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Recombinant Immunotherapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Recombinant Immunotherapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Recombinant Immunotherapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Recombinant Immunotherapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Recombinant Immunotherapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Recombinant Immunotherapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Recombinant Immunotherapeutics Sales Volume Share by Application (2018-2023)

    • Table Capricor Company Profile

    • Table Capricor Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table Janssen Company Profile

    • Table Janssen Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table UCB Company Profile

    • Table UCB Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table United Therapeutics Company Profile

    • Table United Therapeutics Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table Octapharma Company Profile

    • Table Octapharma Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table Grifols Company Profile

    • Table Grifols Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table Takeda Company Profile

    • Table Takeda Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table NeuroDerm Company Profile

    • Table NeuroDerm Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table Ferring Company Profile

    • Table Ferring Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table SteadyMed Company Profile

    • Table SteadyMed Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table Baxter Company Profile

    • Table Baxter Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table Britannia Company Profile

    • Table Britannia Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table Rhythm Metabolic Company Profile

    • Table Rhythm Metabolic Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Recombinant Immunotherapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US